ObjectivesIn order to provide baseline data for the establishment of urban health indicator system in China and other cities, the indicators, characteristics and problems of 24 urban health indicator systems in China were researched.MethodsCNKI, Wan Fang Data, VIP, as well as China’s all provinces and cities’ websites of government and family planning commission and patriotic health campaign commission were searched to collect literatures and government documents on " Healthy city” and its index system. They were then been extracted, classified and summarized.ResultsThe final search involved 24 healthy city indicators system in China, including 1 531 indicators and 14 dimensions, 5 operations and 8 special operations. Seven dimensions (health, health services, environmental health, social indicators, indicators of policy, indicator of health promoting) were widely used. 38 indicators were used above five times, while 441 indicators were used merely once.ConclusionsThe structure of urban health indicator systems in China are almost consistent with WHO’s. They all have the characteristics of diversity, characteristic, national policy, civilian etc. However, there still exists problems with indicators of quantity, definition, classification and lack of indicators on mental health, children health, pregnant woman health as well as elderly health. It is urgent to develop the principles, methods, processes and standards for urban health indicators.
Rational drug use is a global concern. As one of the highest risk groups for drug use, children's rational drug use has always been concerned. Based on the previous research results of the research group, we developed evaluation indicator systems for assessing rational drug use to treat community-acquired pneumonia and primary nephrotic syndrome in children and proton pump inhibitors in pediatric intensive care units and finished empirical research. This study further summarizes and expounds the construction ideas of rational drug use evaluation indicators for children based on diseases or drugs, and provides a reference for constructing children's rational drug use evaluation indicators.
Objective To systematically review published methodological guidelines for health technology assessment (HTA) at home and abroad. Methods Common electronic databases, guideline databases, international networks of HTA agencies/organizations, representative national HTA networks and official websites of governmental health departments were extensively searched and screened to identify guidelines for conducting or reporting HTA from inception to April 24, 2023. Basic information on guidelines, HTA processes, assessment indicators, reporting checklists and other information was extracted, analyzed and described using a systematic review methodology. Results A total of 41 guidelines were included in this study, published from January 2002 to January 2023; the publishing institutions involved 23 countries/international organizations, and 6 languages; the assessments were mainly for all health technologies (n=23), pharmaceuticals (n=4), diagnostic/testing technologies (n=4), non-pharmaceutical health technologies (n=3), medical devices/equipment (n=3), hospital health technologies (n=2), medical and surgical interventions (n=1), and screening technologies (n=1); the assessment perspectives were mainly health system perspectives (n=16), societal perspectives (n=12), and hospital perspectives (n=3), while the rest did not provide information on the perspectives; 28 guidelines described the detailed HTA assessment process, involving 11 steps; there were 39 guidelines described the assessment domains and related assessment indicators in detail, ranging from 2 to 9 assessment domains and involving 10 first-level assessment indicators; a checklist for HTA reports listed in 10 guidelines, involving 18 report entries; 17 guidelines reported conflicts of interest, mostly no conflicts of interest (n=10), and 3 of the remaining 7 guidelines did not indicate a specific conflict of interest, while 4 guidelines in which possible sources of conflict of interest were indicated. Conclusion The development of HTA has formed a relatively perfect assessment system, but there is a need to unify the criteria for classification of health technologies and reporting checklist, improve the specificity indicators for different types of health technologies, and clarify the assessment perspectives. Combined with the current situation of HTA development in China, contextualized guidelines for HTA implementation and reporting should be formulated to provide scientific information and methodological basis for decision-making on rational allocation of health resources.